Verana Health Announces New Multiple Sclerosis Real-World Data Module

Verana has announced development of a new Neurology Qdata module for multiple sclerosis (MS) research. Qdata MS adds real-world data (RWD) from the American Academy of Neurology’s Axon Registry to the Neurology Qdata platform, further bolstering the company’s real-world evidence (RWE) resources.

According to PR Newswire, “Qdata MS provides quality insights into the patient population by applying artificial intelligence to the unstructured data found in clinical notes to help provide a more complete understanding of disease activity and clinical characteristics such as MS phenotype, Expanded Disability Status Score (EDSS) score, and clinical relapse. Using de-identified electronic health record (EHR) data, detailed diagnostic classification beyond international classification of diseases (ICDs), and a granular understanding of disease activity, researchers can gain a better understanding of the MS patient journey.”

To read more, click here.

(Source: PR Newswire, November 17^th, 2022)